We are working to secure treatment locations in major cities within California. Joining our waitlist helps us prioritize which cities we should come to next. Sign up to receive early access to treatment once available.

We are currently accepting a select number of insurance providers in partnered states like California, New York, Washington and Colorado. Stay informed by checking our list of accepted providers here.

For patients outside of our partnered states, we are also committed to making behavioral health services accessible to everyone. To further this commitment, we are actively working on expanding our list of accepted insurance providers, and establishing partnerships beyond our partnered states. 

In the meantime, we can always issue a superbill for out-of-network (OON) reimbursement upon request.

At this time, Spravato has received FDA approval to specifically treat Major Depressive Disorder with Acute Suicidal Ideation and Treatment Resistant Depression. Patients who are seeking ketamine treatment for other conditions may be eligible for at-home treatment using oral ketamine. Oral ketamine can be prescribed off-label for psychiatric conditions including depression, anxiety, and PTSD.